Emerson Acquires Fluxa
June 30, 2022
Emerson has acquired Fluxa, a Glendale, California-based life sciences software provider whose PKM solution accelerates tech transfer and drug development. The deal strengthens Emerson’s life sciences automation and software portfolio by integrating Fluxa’s technology with Emerson’s DeltaV control system to improve speed to market and manufacturing flexibility for biopharma customers.
- Buyers
- Emerson
- Targets
- Fluxa
- Industry
- Software
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Emerson Acquires Fluxa (after earlier equity investment)
February 25, 2021
Software
Emerson (NYSE: EMR) initially made an equity investment in Fluxa in February 2021 to accelerate the development and commercialization of Fluxa’s Process & Knowledge Management (PKM) life‑sciences software. Emerson later completed a full acquisition of Fluxa (announced June 30, 2022) to integrate Fluxa’s PKM capabilities with Emerson’s life‑sciences automation and execution systems.
-
Cell Microsystems Acquires Fluxion Biosciences
August 23, 2023
Medical Devices
Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.
-
BlueCrest (Platinum Equity Portfolio) Acquires Fluence Automation
November 1, 2021
Industrial Services
Danbury, Connecticut-based BlueCrest, a Platinum Equity portfolio company, has acquired Arlington Heights, Illinois-based Fluence Automation. The acquisition brings Fluence's sortation, material handling and postal automation hardware and software into BlueCrest's solution stack to expand capabilities in e-commerce fulfillment and parcel/postal sortation markets.
-
Illumina Acquires Fluent BioSciences
July 9, 2024
Biotechnology
Illumina, Inc. has acquired Fluent BioSciences to integrate Fluent's PIPseq single-cell technology into Illumina's product portfolio and accelerate its multiomics capabilities. The acquisition, which closed July 9, 2024 and was funded with cash on hand, brings Fluent's accessible, scalable single-cell chemistry and the Fluent team into Illumina to expand end-to-end single-cell solutions for research and applied customers.
-
FluidAI Medical Acquires Emmetros Limited (SparxConnect)
November 26, 2025
Healthcare Services
FluidAI Medical acquired Emmetros Limited, the developer of the SparxConnect patient engagement platform, to integrate its capabilities into FluidAI's Stream Inara offering. The deal strengthens FluidAI's RISE surgical recovery suite by expanding patient education, continuous engagement, and post-discharge monitoring to support earlier discharge and improved recovery outcomes.
-
Flexera Acquires Snow Software
February 15, 2024
Software
Flexera has completed the acquisition of Snow Software, combining Flexera's technology value optimization platform with Snow's software asset management and SaaS/FinOps capabilities to provide broader visibility and cost controls across hybrid IT environments. The deal brings together complementary product portfolios and domain expertise to expand capabilities for ITAM, SaaS management and FinOps for enterprise customers worldwide.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.